Navigation Links
China Cord Blood Corporation Reports First Quarter Fiscal 2011 Financial Results
Date:9/10/2010

8 53,902 61,349 Inventories 1,126 7,635 5,070 Prepaid expenses and other receivables 1,591 10,788 13,137 Deferred tax assets 612 4,151 3,443 Total current assets 58,953 399,791 363,834 Property, plant and equipment, net 36,546 247,836 250,491 Non-current prepayments 1,199 8,128 151,138 Non-current accounts receivable, less allowance for doubtful accounts (June 30, 2010: RMB12,567; March 31, 2010: RMB9,181) 28,517 193,386 176,874 Inventories 4,546 30,830 29,637 Intangible asset, net 3,842 26,054 26,297 Available-for-sale equity securities 5,502 37,313 48,475 Other investment 20,575 139,532 -- Deferred tax assets 83 565 288 Total assets 159,763 1,083,435 1,047,034 LIABILITIES Current liabilities Bank loan 6,636 45,000 45,000 Accounts payable 966 6,549 5,410 Accrued expenses and other payables 3,241 21,976 22,475 Deferred revenue 6,361 43,135 36,074 Amounts due to related parties 436 2,960 2,977 Income tax payable 769 5,217 4,098 Total current liabilities 18,409 124,837 116,034 Deferred revenue 15,214 103,174 93,155 Other non-current liabilities 2,668 18,096 15,978 Deferred tax liabilities 282 1,910 2,259 Total liabilities 36,573 248,017 227,426 CHINA CORD BLOOD CORPORATION UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS As of June 30 and March 31, 2010 ¨C (continued) June 30, March 31, 2010 2010 US$ RMB RMB (in thousands except share data) EQUITY Shareholders' equity Ordinary shares - US$0.0001 par value, 250,000,000 shares authorized, 67,025,096 shares and 66,743,693 shares issued and outstanding as of June 30 and March 31, 2010, respectively 7 46 46 Additional paid-in capital 107,496 728,983 719,329 Accumulated other comprehensive (loss)/income (1,570) (10,642) 2,221 Retained earnings 15,465 104,876 87,290 Total shareholders' equity 121,398 823,263 808,886 Noncontrolling interests 1,792 12,155 10,722 Total equity 123,190 835,418 819,608 Total liabilities and equity 159,763 1,083,435 1,047,034
'/>"/>
SOURCE China Cord Blood Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. China-Biotics Ranked Number 62 on FORTUNES 100 Fastest-Growing Companies List
2. Reportlinker Adds Advances in Biopharmaceutical Technology in China
3. China BCT Reports Strong Second Quarter 2010 Results
4. China Biologic Products Announces Record Second Quarter 2010 Results
5. China Biologic Products to Attend Canaccord Genuity 30th Annual Growth Conference
6. China BCT Further Expands its Footprint by Opening 12 New Retail Pharmaceutical Stores
7. VIASPACE CEO Discusses Giant King Grass at Industrial Biotechnology Congress in China
8. Orchestrall Sponsors China Business Toolbox: Brings Focus to the How and When of China Market Access
9. China-Biotics to Report Fiscal Year 2011 First Quarter Financial Results on August 9
10. Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016
11. China Cord Blood Corporation Announces Cancellation of Nine Million Management Incentive Warrants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... Cytochroma today announced that it has appointed John Cunningham, ... Advisory Board. , Dr. Cunningham is Professor of Nephrology ... at the Royal Free Hospital, London. His early training ... in The University of London and Washington University ...
... , SLINGERLANDS, N.Y., Oct. 15 Sabre Technical Services ... to the problems experienced by U.S. homeowners and builders ... Sabre,s solution is an adaptation of its patented chlorine ... and smaller buildings. , Sabre has a long history ...
... ... Inc. announced that it completed its pre-IND meeting with the U.S. Food ... evaluate the safety and efficacy of Stemedica,s high potency proprietary allogeneic mesenchymal ... Based on a meeting October 13, 2009 with the FDA, Stemedica is ...
Cached Biology Technology:Cytochroma Appoints Dr. John Cunningham to its Scientific Advisory Board 2Cytochroma Appoints Dr. John Cunningham to its Scientific Advisory Board 3Sabre Announces Roll-Out of Permanent Solution to Chinese Drywall Problems 2Sabre Announces Roll-Out of Permanent Solution to Chinese Drywall Problems 3Stemedica Completes Meeting with the FDA 2Stemedica Completes Meeting with the FDA 3
(Date:11/21/2014)... According to a new market research report ... Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), End ... - Global Forecasts to 2020", published by MarketsandMarkets, The ... $25 Billion in 2014 and is expected to reach ... 8.69%. Browse 116 market data Tables and ...
(Date:11/21/2014)... 20, 2014   Atmel® Corporation (NASDAQ: ... and touch technology solutions, today launched the industry,s first ... the widest V cc range from 1.7V to ... faster I 2 C bus communication speeds, and are ... making them ideal for consumer, industrial, computer, and medical ...
(Date:11/18/2014)...   EyeLock Inc. , a market leader ... USA (Safran), a leading U.S. provider of ... partnership to offer comprehensive biometric identity solutions and ... screening and financial services markets. As ... through a nationwide network of 1,100 IdentoGO® Centers.  ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... and other senior female family members should play a key ... in non-Western societies. However, they are often overlooked by health ... see them as an obstacle to promoting good nutrition and ... extensive literature review published in the January issue of ...
... celebrates its 50,000th eBook, available on its online ... Springer,s position as the largest eBook publisher and ... comprehensive online collection of science, technology and medicine ... addition, as announced in October 2011, Springer will ...
... may soon benefit from an experimental drug being tested by ... Texas A&M College of Veterinary Medicine & Biomedical Sciences ... similar injuries. Funded through a three-year, $750,000 grant from ... has already proven effective in mice at UCSF. Now the ...
Cached Biology News:Research highlights key role grandmothers play in mother and child nutrition and health 2Research highlights key role grandmothers play in mother and child nutrition and health 3SpringerLink now offers more than 50,000 eBooks 2Saving dogs with spinal cord injuries 2
BAI-1 (T-20)...
MOUSE ANTI HUMAN CYTOKERATIN 1-8...
GOAT ANTI HUMAN PSA (ISOFORM 1)...
... peptide derived from the N-terminal region of ... Specificity: Specific for the N-terminus of the ... Dog Rat Mouse (positive controls: MDCK-II A431 ... heart blood vessel and brain mossy fiber ...
Biology Products: